ArticleFrontiers in oncology2026
Quantitative peri-lesional densitometry mapping via thin-slice volume rendering enhances differentiation of pneumonic-type lung cancer and inflammatory pneumonia.
Article in Frontiers in oncology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objectives: Pneumonic-type lung cancer (PTLC) poses significant diagnostic challenges owing to its overlapping computed tomography (CT) imaging appearance with inflammatory pneumonia. We developed and validated a novel diagnostic model that integrates densitometry-derived thresholds into modified thin-slab volume rendering (tsVR) to differentiate PTLC from inflammatory pneumonia. We further evaluated and compared the diagnostic performance of this tsVR approach against conventional CT feature-based diagnosis. Materials and methods: This retrospective study enrolled 383 patients (193 PTLC, 190 pneumonia) for model development (training/internal validation cohorts, 7:3 ratio) and 61 patients as external validation cohort. Peri-lesional densitometric analysis identified voxel-level and individual-level CT density thresholds translated into modified tsVR parameters to enhance the peri-lesional visualization. Discriminating capabilities of tsVR were assessed by four radiologists against original CT feature-based diagnosis using the area under curve (AUC), sensitivity, specificity, accuracy, positive predictive value (PPV), negative predictive value (NPV), F1-score, F2-score and Matthews correlation coefficient (MCC), followed by logistical regression analyses assessing independent influencing factors for diagnostic accuracy. Results: The tsVR model achieved superior performance over original CT feature-based diagnosis across all metrics, with internal validation AUC 0.86 (sensitivity 0.90, specificity 0.82, accuracy 0.86, F2 score 0.89) and external validation AUC 0.81 (sensitivity 0.90, specificity 0.73, accuracy 0.82, F2 score 0.87). Logistical regression analyses confirmed robustness of tsVR in diagnostic accuracy across scanners, scanning doses and reconstruction protocols, with good inter-observer agreement (κ=0.713). Conclusion: The tsVR significantly improves the diagnostic efficacy in discriminating PTLC from inflammatory pneumonia, demonstrating clinical applicability and robust stability.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.